SECURITIES GOVERNANCE | 2026-06-12
Nasdaq's $5 Million MVLS Rule: Small-Cap Delisting Risk
Nasdaq's proposed continued-listing standard requiring a minimum $5 million Market Value of Listed Securities, the 30-consecutive-business-day no-cure-period suspension mechanic, the SEC's April 28, 2026 order instituting proceedings that leaves the rule pending, and the NYSE American companion proposal create heightened delisting risk for California small-cap technology, biotechnology, and life-sciences issuers listed on the Nasdaq Capital Market.
By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published
On January 13, 2026, Nasdaq filed a proposed rule requiring listed companies to maintain at least $5 million in Market Value of Listed Securities, with a 30-business-day trigger and no cure period; the SEC instituted proceedings on April 28, 2026, leaving the rule pending and creating heightened delisting risk for California small-cap issuers.
Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.
Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301